comparison of glp-1 agonists short-acting versus long-acting receptor GLP-1 Agonist Drugs I -
Description
The figure summarizes FDA-approved and investigational non-diabetes indications for GLP-1RA
Inside the push to get weight loss treatment covered by Medicare
Were doing it because different brand names of the same generic medication have been approved for different indications, so we dont want to cause confusion
This shift in endpoints reflects a broader reframing of obesity as a chronic disease rather than a lifestyle issue
This study tested one potent GLP-1 receptor agonist against another that is less potent but still showed an overall reduction in events, she says
